C4 Therapeutics, Inc. (CCCC)
$3.06-3.16%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $338M
- Beta
- 3.08
- P/E (TTM)
- -2.88
- Short % float
- 48.26%
- Days to cover
- 17.6
- SI change
- +0.5%
- 1W
- +2.34%
- 1M
- -12.82%
- vs SPY 1W
- +1.92%
- vs SPY 1M
- -14.88%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CCCC?
- LOPJLB’s latest quantitative signal on C4 Therapeutics, Inc. (CCCC) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is CCCC in?
- C4 Therapeutics, Inc. (CCCC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does C4 Therapeutics, Inc. (CCCC) do?
- C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutic candidates. Its core strategy involves degrading proteins implicated in disease, addressing a range of conditions including cancer, neurodegenerative disorders, and other illnesses. The company's primary drug candidate, CFT7455, is an orally administered MonoDAC degra…